Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 4,54 MB, PDF-dokument

Metanephric Adenoma (MA) is a rare and unclassifiable renal tumour with sparse reported clinical and morphological features. Generally MA's have a benign course without recurrence after nephrectomy, however a few cases received oncological treatment due to malignant progression. We present a 42-year-old woman who years after an initial nephrectomy developed several processes and biopsy confirmed recurrence of MA. Sunitinib was given for only two weeks, as she developed side-effects and currently the patient undergoes control scans with only minimal growth of the processes. This is the first case of MA treated with Tyrosin-Kinase-Inhibitor.

OriginalsprogEngelsk
Artikelnummer101880
TidsskriftUrology Case Reports
Vol/bind40
Antal sider4
ISSN2214-4420
DOI
StatusUdgivet - 2022

ID: 290109540